These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 25163311

  • 1. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S.
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [Abstract] [Full Text] [Related]

  • 2. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system.
    Sasajima T, Takano Y, Hiraishi Y, Goh K, Inaba M, Azuma N, Sasajima Y, Yamazaki K, Yamamoto H.
    J Vasc Surg; 2000 Aug; 32(2):374-82. PubMed ID: 10917998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR.
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Fluctuations in pulmonary fibrin decomposing activities (plasmin and non-plasmin activities) in an endotoxin DIC model in rats].
    Okamoto U, Sasaki K, Nagao N, Naiki I, Nagamatsu Y.
    Nihon Seirigaku Zasshi; 1982 Aug; 44(11):633-41. PubMed ID: 6221092
    [Abstract] [Full Text] [Related]

  • 12. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW, Chiu WC, Chang HT, Hsu PH, Huang CC.
    Anal Chim Acta; 2013 Apr 24; 774():67-72. PubMed ID: 23567118
    [Abstract] [Full Text] [Related]

  • 13. Concepts of clot lysis.
    Francis CW, Marder VJ.
    Annu Rev Med; 1986 Apr 24; 37():187-204. PubMed ID: 2939790
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.
    Foley JH, Cook PF, Nesheim ME.
    J Biol Chem; 2011 Jun 03; 286(22):19280-6. PubMed ID: 21467042
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasminogen activators: pharmacology and therapy.
    Holden RW.
    Radiology; 1990 Mar 03; 174(3 Pt 2):993-1001. PubMed ID: 2137641
    [Abstract] [Full Text] [Related]

  • 17. The fibrinolytic system in man.
    Collen D, Lijnen HR.
    Crit Rev Oncol Hematol; 1986 Mar 03; 4(3):249-301. PubMed ID: 2420482
    [Abstract] [Full Text] [Related]

  • 18. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
    Hayakawa M, Sawamura A, Gando S, Jesmin S, Naito S, Ieko M.
    Thromb Res; 2012 Dec 03; 130(6):906-13. PubMed ID: 22353215
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.